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Summary
Objective: Sialic acids frequently occur at the terminal positions of glycoprotein N-glycans present at chondrocyte surfaces or in the cartilage
matrix. Sialic acids are transferred to glycoproteins in either a-2,3 or a-2,6 linkage by speciﬁc sialyltransferases (SiaTs) and can potentially
affect cell functions and cellematrix interactions. The present study aimed to assess the relationship between the expression of the human
chondrocyte phenotype and the sialylation of chondrocyte glycoprotein N-glycans.
Methods: The transcription of 5 SiaT was quantiﬁed using real-time Reverse transcription polymerase chain reaction (RT-PCR) assays. N-glycan
analysiswas performed using LCeESI-MS. Primary human chondrocyteswere cultured inmonolayer or alginate beads and compared to the chon-
drocyte cell lines C-28/I2 and SW1353. In addition, effects of interleukin-1b (IL-1b) or tumour necrosis factor-a (TNF-a) on primary cells were
assessed.
Results: Primary human chondrocytes predominantly express a-2,6-speciﬁc SiaTs and accordingly, a-2,6-linked sialic acid residues in glyco-
protein N-glycans. In contrast, the preponderance of a-2,3-linked sialyl residues and, correspondingly, reduced levels of a-2,6-speciﬁc SiaTs
are associated with the altered chondrocyte phenotype of C-28/I2 and SW1353 cells. Importantly, a considerable shift towards a-2,3-linked
sialic acids and a-2,3-speciﬁc SiaT mRNA levels occurred in primary chondrocytes treated with IL-1b or tumour necrosis factor-alpha
(TNF-a).
Conclusion: The expression of the differentiated chondrocyte phenotype is linked to the ratio of a-2,6- to a-2,3-linked sialic acids in chondro-
cyte glycoprotein N-glycans. A shift towards altered sialylation might contribute to impaired cellematrix interactions in disease conditions.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Phenotype.Introduction
The extracellular matrix (ECM) of cartilage consists of nu-
merous glycosylated proteins, which contribute to the main-
tenance of its speciﬁc functions1. Beside structural
proteoglycans such as aggrecan transcript (mRNA), and ad-
hesive proteins such as chondroadherin, glycosylated cell
surface receptors, including CD44 and integrins, play critical
roles in the mediation of chondrocyteematrix interactions1e3.
Protein glycosylation, i.e., the attachment of oligosaccharide
chains to asparagine or serine/threonine residues, repre-
sents a common co-translational and post-translational mod-
iﬁcation of proteins, conferring protection against proteolytic
degradation or controlling protein folding. It is known that*Address correspondence and reprint requests to: Stefan Toegel,
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240carbohydrate chains vary according to tissue and cell type
and are subject to change during development and oncoge-
nesis4e6. In addition, various factors such as cytokines or dif-
ferentiation factors can regulate cellular glycosylation and the
expression of speciﬁc glycosyltransferases7e11. Thus,
changes in the cellular glycophenotype can potentially affect
cell functions such as cell adhesion, cell surface receptor ac-
tivity, and the onset of apoptosis12.
Sialic acids (Neu5Ac in humans) are negatively charged
sugars typically found at the terminal positions of N- and
O-linked oligosaccharides attached to cell surfaces or se-
creted glycoproteins. As a result of their non-reducing termi-
nal position, sialic acids are involved in highly speciﬁc
recognition phenomena, as well as in invasive properties
of cancer cells13e16. The transfer of sialic acids to penulti-
mate galactose or N-acetylgalactosamine groups of glyco-
proteins is mediated by sialyltransferases (SiaTs). The
diverse enzymes of the SiaT family share the cytidine
monophosphate-sialic acid as donor substrate, but are
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they act and by the linkage type they generate (e.g., a-2,3
or a-2,6 linkage in case of N-linked glycans in glycopro-
teins)16. The expression patterns of SiaTs show remarkable
tissue speciﬁcity and appear to be regulated at the tran-
scriptional level. In particular, the altered expression of a-
2,3- or a-2,6-SiaTs and subsequent effects on cell surface
sialylation have been demonstrated to inﬂuence osteoclas-
togenesis, endocytosis in dendritic cells, and adhesion
properties of human colon cancer cells17e19.
Regarding inﬂammatory and degenerative joint diseases,
recent studies have suggested a relationship between al-
tered glycosylation and disease conditions. It is known that
altered N-glycans of serum immunoglobulin G molecules
contribute to the pathophysiology of rheumatoid arthritis20.
In addition, initial evidence for altered N-glycosylation of car-
tilage tissue has been presented using an animal model of
osteoarthritis21. Despite the signiﬁcance of glycoproteins
for ECM assembly in cartilage tissue, however, little is known
about the regulation of the chondrocyte glycophenotype. Re-
cently, we found that differences in the molecular phenotype
between primary human chondrocytes and chondrocyte cell
lines are reﬂected by speciﬁc cellular lectin-binding pat-
terns22,23. In a further study, Yang and coworkers have
shown that cytokine treatment of human and bovine chon-
drocytes results in speciﬁc glycosylation changes related to
apoptosis and altered cell proliferation12.
Owing to the potential implications of the chondrocyte gly-
cophenotype in the pathophysiology of joint diseases such
as osteoarthritis, we set out to examine the sialylation pro-
cesses in human chondrocytes using a combination of
gene expression and N-glycan structural analyses. We
compared the sialylation pattern of primary human chondro-
cytes with those of immortalized chondrocytes C-28/I2 and
chondrosarcoma cells SW1353, and investigated the ef-
fects of interleukin-1b (IL-1b) and tumour necrosis factor-
alpha (TNF-a) on primary chondrocyte (PC) sialylation.
Our ﬁndings provide new information on N-glycan sialyla-
tion in human chondrocytes and demonstrate that the status
of the chondrocyte phenotype is critically linked to the ratio
of a-2,6- to a-2,3-linked sialic acids of chondrocyte glyco-
protein N-glycans.MethodsHUMAN CHONDROCYTE CULTURESHuman articular cartilage was obtained during total knee replacement sur-
geries in patients with osteoarthritis with informed consent and in accordance
with the terms of the ethics committee of the Medical University Vienna (EK-
Nr.: 081/2005). PCs were isolated according to protocols published previ-
ously22, seeded as high density monolayers (MLs) (105 cells/cm2), and
grown in an atmosphere of humidiﬁed 5% CO2/95% air at 37
C using
Dulbecco’s Modiﬁed Eagle Medium supplemented with 10% fetal calf serum
(Biochrom AG, Germany), 2 ml/ml gentamycin, and 50 mg/ml ascorbate as
culture medium (complete medium). Only freshly isolated cells were plated
for all assays throughout the study. To induce inﬂammatory conditions,
PCs were treated with 10 ng/ml IL-1b or 40 ng/ml TNF-a for the time periods
indicated. Three-dimensional (3D) chondrocyte cultures were established in
alginate beads according to standard procedures and cultured for 3 weeks
as described24. Immortalized chondrocytes C-28/I2, and chondrosarcoma
cells SW1353, were seeded at 9.3 103 cells/cm2 and maintained in com-
plete medium.QUANTITATIVE REAL-TIME PCRChondrocytes were grown in duplicate wells in 12-well tissue culture
plates (Iwaki, Japan) to 90% conﬂuence prior to treatment with cytokines
for 24 h. Total RNA was extracted using the NucleoSpin RNA II Kit
(Macherey-Nagel, Germany). Each sample was run on the Agilent 2100Bioanalyzer Nano LabChip for quality control and quantiﬁcation of total
RNA prior to reverse transcription into cDNA using the high capacity cDNA
reverse transcription kit (Applied Biosystems, Austria).
SYBR-green based qPCR assays for the sialyltransferase transcripts
ST6Gal1 (NM_003032), ST6Gal2 (NM_032528), ST3Gal3 (NM_174963),
ST3Gal4 (NM_006278), and ST3Gal6 (NM_006100) were established. Am-
pliﬁcation efﬁciencies of all primers were between 90 and 105% as evaluated
using dilution series of cDNA prepared from chondrocyte mRNA. Primers
and results of melting curve analyses are shown in Supplementary Table 1
and Supplementary Fig. 1, respectively. qPCR reactions for transcripts
from collagen type I (COL1), collagen type II (COL2) and aggrecan AGC
were performed according to protocols published recently25. mRNA expres-
sion levels were calculated as relative copy numbers considering actual am-
pliﬁcation efﬁciencies and with respect to that of glyceraldehyde-3-
phosphate-dehydrogenase (GAPDH) set at 1000. The regulation of a target
gene by cytokines was calculated as quantities relative to the untreated con-
trol group using the MxPro real-time QPCR software, considering both ampli-
ﬁcation efﬁciencies and normalization to GAPDH.PROTEIN ISOLATION AND N-GLYCAN PREPARATIONChondrocytes were seeded in 25 cm2 ﬂasks (Greiner bio-one, Austria)
and allowed to settle for 48 h. Then, the culture medium was changed and
cells were maintained in the presence of 10 ng/ml IL-1b or 40 ng/ml TNF-
a for 5 days. Cells were carefully washed ﬁve times with PBS buffer and
scraped in the presence of 200 ml lysis buffer (containing protease inhibitor).
After centrifugation for 5 min at 12,000 rpm, the pellet was washed once with
PBS buffer and centrifuged again. The combined supernatants were mixed
with three times the volume of acetone (20C for 30 min) to precipitate pro-
teins. Further protein puriﬁcation and glycan isolation was performed using
the ‘in-gel release method’ as described by Rendic et al.26 Brieﬂy, the precip-
itate was dissolved in SDS-PAGE sample buffer and subjected to
SDS-PAGE, but only to the point when the unseparated protein zone had
just entered the separation gel. Free N-glycans were isolated from this
band by trypsin and PNGase F digestion. The released asparagine-linked
glycans were reduced with 50 ml of 1% NaBH4 at room temperature for
4 h. To remove excess salt, the sample was further puriﬁed using a 10 mg
HyperSep Hypercarb SPE cartridge (Thermo Scientiﬁc, USA), according to
previous protocols27.QUANTIFICATION OF OLIGOSACCHARIDES USING LCeESI-MSRecent work on ﬁbrin N-glycans and immunoglobulin glycosylation re-
vealed the ability of porous graphitic carbon (PGC) phases to separate iso-
meric glycans with a subsequent sensitive detection of both neutral and
sialylated glycans by using ESI-MS28,29. The recently established retention
time library of mammalian, diantennary glycans varying in the linkage of si-
alic acid was applied for the structural assignment of the peaks. LCeESI-
MS, using graphitized carbon as the separation phase (PGCeESI-MS),
outperforms other glycan analysis methods including MALDI-TOF or NMR
spectroscopy in terms of minimal sample consumption, minimal sample
preparation, and the reliable qualitative and quantitative recording of neutral,
mono- and di-sialylated structures with concomitant identiﬁcation of isomeric
structures26e28.
Analysis of borohydride-reduced oligosaccharides (from an aliquot equiv-
alent to 2.5 105 cells) by positive-ion LCeESI-MS was performed with
a 100 0.32 mm PGC column (Thermo) and a ﬂow rate of 5 ml/min main-
tained with a Dionex Ultimate 3000 cap ﬂow system, as described re-
cently28,29. Mass analysis was done with a Waters Q-TOF Ultima Global
mass spectrometer with standard ESI-source and MassLynx V4.0 SP4 soft-
ware for evaluation and quantiﬁcation of obtained peak areas. Individual
analyses were averaged, with a mean deviation for the relative glycan quan-
tities of approximately 0.05 units.CELL MORPHOLOGYPCswere seeded on glass cover slips and cultured for 48 h in completeme-
dium. Then, cells were exposed to 10 ng/ml IL-1b or 40 ng/ml TNF-a for up to 5
days. Using conventional light microscopy, cell morphological alterations were
observed with regard to the formation of a spindle-shaped cell conﬁguration,
which is associated with a dedifferentiated ﬁbroblast-like phenotype.CELL PROLIFERATIONPCs of two donors were seeded into 96-well microplates (Iwaki, Japan) and
cultured for 48 h. Then, cells were treated in quadruplicate with 10 ng/ml IL-1b
or 40 ng/ml TNF-a for 24 h. The total number of cells was determined using the
CyQuant assay kit (Molecular Probes, USA) pursuing a modiﬁed protocol30.
Moreover, the rate of proliferation of cells was assessed by incorporation of
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assay (Roche, Germany), according to the manufacturer’s instructions.SULFATED GLYCOSAMINOGLYCAN (sGAG) ASSAYPCs were seeded in triplicate into six-well tissue culture plates (Iwaki,
Japan) and cultured for 48 h prior to treatment with 40 ng/ml TNF-a for 5
days. An improved 1,9-dimethyl-methylene blue (DMMB) colorimetric assay
was performed according to Barbosa et al.31 to assess both cell-associated
sGAG and sGAG released into the culture medium. Absorbance of the sam-
ples was measured at 656 nm and related to equivalent cell numbers, which
were determined using the CyQuant assay kit. The experiment was repeated
twice using cells from different donors.STATISTICSData were exported to the GraphPad Prism statistics software package
(GraphPad Prism Software, USA). The Gaussian distribution of the data
was veriﬁed using the KolmogoroveSmirnov test. Statistics were performed
using one-way analysis of variance (ANOVA) with post-hoc Tukey tests,
cross-comparing all study groups (95% conﬁdence interval) consisting of in-
dependent mean values. P-values <0.05 were considered signiﬁcant.ResultsEXPRESSION PROFILES OF SiaT GENES IN HUMAN
CHONDROCYTE MODELSThe mRNA levels of ﬁve SiaTs were determined with re-
spect to GAPDH in human chondrocytes using qPCR. Table
I shows the SiaT expression levels in PCs cultured as MLs
or in alginate beads (3D), as well as in SW1353 and C-28/I2
cell lines. In general, SiaTs were expressed at low levels in
all cell models. In MLs of PCs (n¼ 10 donors), ST6Gal1
showed the highest abundanceof all evaluatedSiaTs. In com-
parison to ST6Gal1, ST6Gal2 was expressed at more than
400-fold lower levels. In addition, the mRNA levels of the
a-2,3-SiaTs (ST3Gal3, ST3Gal4, and ST3Gal6) were all low
compared to ST6Gal1. Among the a-2,3-SiaTs, ST3Gal4
was the gene with the highest expression level. All in all, the
SiaT expression proﬁle of PCs predicts a sialylation pattern
in which a-2,6-linked sialylation predominates over a-2,3-sia-
lylation. When cultured in alginate beads, PCs expressed
comparable levels of a-2,6-SiaTs and slightly reduced levels
of ST3Gal3 and ST3Gal4 (1.6-fold and 1.9-fold, respectively).
When comparing the chondrosarcoma cell line SW1353 with
PCs, we observed remarkably diminished (2.5-fold) ST6Gal1
expression in SW1353 cells, whereas mRNA levels of
ST3Gal4 were slightly increased. The SiaT proﬁle of C-28/I2
chondrocytes was characterized by almost completely sup-
pressed ST6Gal1 mRNA levels, whereas the a-2,3-SiaT pro-
ﬁle only showed minor alterations in comparison to PCs.
Taken together, primary human chondrocytes are character-
ized by a predominant expression of a-2,6-SiaT, predicting
the preponderant presence of a-2,6-linked terminal sialicTable I
mRNA expression of N-glycan related sialyltransferases (SiaTs).
mRNA levels were quantified using qPCR and expressed as rela-
tive copy numbers with respect to GAPDH set at 1000. PCs cul-
tured in ML or alginate beads (3D) were compared to SW1353
chondrosarcoma cells and immortalized C-28/I2 chondrocytes.
cDNA of PCs from 10 donors was pooled and analyzed in triplicate.
Mean values of the samples are presented
Cells ST6Gal1 ST6Gal2 ST3Gal3 ST3Gal4 ST3Gal6
PC (ML) 17.5 <0.1 3.8 4.7 1.1
PC (3D) 15.8 <0.1 2.3 2.5 1.1
SW1353 6.8 <0.1 1.3 5.8 0.4
C-28/I2 <0.01 0.2 2.2 5.3 1.1acid residues on PC glycoprotein N-glycans. In contrast, im-
mortalized and chondrosarcoma cell models feature a SiaT
expression proﬁle shifted towards a-2,3-SiaTs.SIALYLATION OF CHONDROCYTE GLYCOPROTEIN
N-GLYCANS IN HUMAN CHONDROCYTE MODELSSialylation patterns and linkage types of chondrocyte gly-
coprotein N-glycans were determined using LCeESI-MS.
Figure 1(A) shows the structure of the diantennary H5N4F
glycan and its possible sialylated isomers analyzed in this
study. Both the abbreviated composition and the full struc-
tural description according to the proglycan system are pre-
sented29,32. These glycans were selected for quantiﬁcation
since they represent a common modiﬁcation of cellular pro-
teins and are among the most abundant glycan structures in
the human chondrocyte glycome (own unpublished result).
Moreover, they are practically absent in fetal calf serum-
containing cell culture medium minimizing the risk of me-
dium-dependent glycan structure contamination.
Using LCeESI-MS online analysis via PGC column, we
quantiﬁed free H5N4F1 structures as well as H5N4F1 gly-
cans carrying one or two sialic acid residues in a-2,6- or/
and a-2,3-linkage and compared them across various PC
models. As shown in Fig. 1(B), the proportional distribution
of the different H5N4F1 glycans was strongly dependent on
cell type and culture conditions. In PCs cultured as MLs, the
majority of diantennary glycans carried one a-2,6-linked si-
alic acid (45.4%), whereas only 11.3% were decorated by
one a-2,3-linked sialic acid residue. Among the
S2H5N4F1 glycans, most structures (21.2%) carried both
one a-2,6-linked and one a-2,3-linked sialic acid. In compar-
ison to this mixed type, S2(a-2,6)H5N4F1 and S2(a-
2,3)H5N4F1 structures were generated at 3-fold lower
levels. In 3D-culture systems, PCs expressed a sialylation
pattern characterized by increased levels of H5N4F1
glycans carrying one or two a-2,6-linked sialic acids.
Concomitantly, those structures decorated with one or two
a-2,3-linked sialic acids were produced at reduced levels.
Of note, the sialylation pattern of N-glycans of SW1353
chondrosarcoma cells showed an inverse trend towards
signiﬁcantly reduced S1(a-2,6)H5N4F1 and S2(a-
2,6)H5N4F1 structures and increased S1(a-2,3)H5N4F1
and S2(a-2,3)H5N4F1 glycans. This trend was even inten-
siﬁed in the C-28/I2 cell line, where a-2,6-linked sialylation
was practically absent, while the majority of H5N4F1 gly-
cans (87.8%) carried terminal sialic acids in a-2,3-linkage.
In summary, sialylation patterns of chondrocyte N-glycans
showed alteration towards increased a-2,6-/a-2,3-sialyla-
tion ratios in 3D-culture and decreased a-2,6-/a-2,3-sialyla-
tion ratios in SW1353 and C-28/I2 cells.INFLAMMATORY CYTOKINES INDUCE CHONDROCYTE
DEDIFFERENTIATIONANDASHIFTOFa-2,6-/a-2,3-SIALYLATIONFigure 2 conﬁrms that PCs undergo dedifferentiation un-
der treatment with pro-inﬂammatory cytokines IL-1b and
TNF-a33. Morphological changes of chondrocytes towards
a spindle-shaped ﬁbroblast-like phenotype were observed
after exposure to cytokines [Fig. 2(A)]. Moreover, both
IL-1b and TNF-a reduced chondrocyte proliferation
[Fig. 2(B)] and expression of chondrocyte marker genes
AGC and COL2 [Fig. 2(D)], resulting in decreased COL2/
COL1 ratios34. In addition, TNF-a decreased the production
of both cell-associated and secreted sGAG, further support-
ing cellular dedifferentiation [Fig. 2(C)].
AB
Fig. 1. Analysis of sialylated and free H5N4F1 glycans in human chondrocytes. (A) Scheme showing all the diantennary N-glycans considered
in this study with the abbreviated composition and the full structural description according to the proglycan system29,32. S stands for sialic acid,
H for hexose, N for N-acetylglucosamine (GlcNAc) and F for fucose. (B) Proportional distribution of free and sialylated H5N4F1 glycans in
human chondrocytes. PCs cultured in ML or alginate beads (3D) are compared to SW1353 chondrosarcoma cells and immortalized C-28/
I2 chondrocytes. PCs from three donors were analyzed in triplicate and respective mean values are presented. The standard deviations
were between 1 and 10% of the mean values for all measurements.
243Osteoarthritis and Cartilage Vol. 18, No. 2To test whether the linkage type of chondrocyte N-gly-
cans was altered under inﬂammatory conditions, SiaT
mRNA expression and N-glycan sialylation were deter-
mined in PCs (n¼ 6 donors) after treatment with pro-inﬂam-
matory cytokines. Figure 3(A) and (B) shows the log-fold
change of SiaT mRNA levels following IL-1b and TNF-
a treatment, respectively. ST6Gal1 mRNA levels were
markedly reduced under the inﬂuence of the cytokines
(4.7-fold in case of IL-1b and 3.3-fold in case of TNF-a),
whereas the expression of ST3Gal4 was enhanced under
the same conditions (2.8-fold and 3.2-fold, respectively).
ST6Gal2, ST3Gal3, and ST3Gal6 were also subject to re-
duction in the presence of IL-1b or TNF-a. Given the differ-
ent steady-state expression levels of the single SiaTs
(Table I), the contribution of each gene to the entire SiaT
pool is displayed graphically in Fig. 3C. It is obvious that
the a-2,3-SiaTs predominate after exposure of chondro-
cytes to IL-1b or TNF-a. In general, diminished ST6Gal1
and increased ST3Gal4 levels appear to be responsible
for this shift towards reduced a-2,6-/a-2,3-SiaT mRNA ra-
tios under inﬂammatory conditions.
Analysis of N-glycan sialylation using LCeESI-MS con-
ﬁrmed the predicted differential expression of a-2,6- and
a-2,3-sialic acid residues after cytokine treatment. Interest-
ingly, the described shift in SiaT mRNA levels was not imme-
diately followed by a preponderance of a-2,3-linked sialyl
residues in the total of glycoprotein glycans, since no signiﬁ-
cant alteration was detected by LCeESI-MS after 24 h of
cytokine treatment (data not shown). However, followinga5-day exposure of the cells to TNF-a or IL-1b, a correspond-
ing shift of a-2,6- towards a-2,3-linked sialylation was
observed. Figure 4 presents detailed information on the alter-
ation of sialylated H5N4F1 structures in chondrocytes from
three donors, indicating that both S2(a-2,6)H5N4F1 and
S1(a-2,6)H5N4F1 were signiﬁcantly decreased, whereas
those structures containing a-2,3-linked sialic acids (S1(a-
2,3)H5N4F1, S2(a-2,6/a-2,3)H5N4F1, S2(a-2,3)H5N4F1)
were enhanced by both cytokines. The most striking differ-
ences were observed in shift of S1(a-2,6)H5N4F1 and
S2(a-2,3)H5N4F1 glycans under TNF-a exposure, resulting
in a 0.6-fold decrease and 2.5-fold increase, respectively. A
representative LCeESI-MS chromatogram of S2H5N4F1
glycans under the inﬂuence of TNF-a or IL-1b is provided
as Supplementary Fig. 2 and illustrates the underlying
analytic principle, used to compare untreated PCs with cyto-
kine-treated cells. Taken together, alterations of the chondro-
cyte phenotype induced by TNF-a or IL-1b were
accompanied by decreasing a-2,6-/a-2,3-SiaT mRNA ratios
and corresponding shifts of sialylated N-glycans towards
a-2,3-sialylated H5N4F1 structures.Discussion
Sialylation of cell surface glycoproteins plays a key role in
many biological processes, including cellematrix interac-
tions. Although disturbed cellematrix interactions are of fun-
damental importance in the onset of degenerative joint
AD
B C
Fig. 2. Phenotypic changes of primary human chondrocytes under exposure to inﬂammatory cytokines. (A) Morphological change of chondro-
cytes under exposure to TNF-a for 24 h. (B) Altered cell number (white bars) and proliferation rate (black bars) of chondrocytes treated with
IL-1b and TNF-a. Data are presented as mean valuesSD. (C) Reduced sGAG content in chondrocytes treated with TNF-ameasured in cells
(white bars) and culture medium (black bars). Data are presented as mean valuesSD. (D) Fold-changes of AGC, COL2 and COL1 tran-
scription in human chondrocytes isolated from three donors (PC1, PC2, PC3) and exposed to IL-1b and TNF-a with respect to untreated cells
(control).
244 S. Toegel et al.: Sialylation of human chondrocytesdiseases including osteoarthritis1,35,36, little is known about
the sialylation patterns in human chondrocytes and their in-
volvement, if any, in cartilage breakdown processes. This
gap in our knowledge may result, at least in part, from the
methodological challenges due to low SiaT transcription
levels and linkage-type speciﬁc glycoprotein N-glycan anal-
ysis in human chondrocytes. Up to the present, evidence for
the sialylation of chondrocytes has been generated using
lectin histochemistry37, lectin-binding studies22, enzyme-
linked lectin assays12,38, and enzyme activity assays12. In
this study, we have employed an advanced approach to
characterize the chondrocyte glycophenotype. Linking to-
gether qPCR and LCeESI-MS techniques, we correlated
quantitatively the gene expression of a-2,6- and a-2,3-spe-
ciﬁc SiaTs with the presence of a-2,6- and a-2,3-linked
sialyl groups in chondrocyte glycoprotein N-glycans.
We here present two lines of evidence indicating that the
chondrocyte phenotype is linked to speciﬁc sialylation pat-
terns of chondrocyte glycoprotein N-glycans. Firstly, thesialylation of various in vitro chondrocyte models with well
known phenotypic differences was investigated. Secondly,
the sialylation of primary human chondrocytes was evalu-
ated after treatment with IL-1b or TNF-a, two cytokines
with pathophysiological signiﬁcance in inﬂammatory joint
diseases.
Despite the value of chondrocytic cell lines, such as the
C-28/I2 and SW1353 cell lines used here, that are used fre-
quently as surrogates for primary human chondrocytes in vi-
tro, they differ markedly from PCs in their molecular
phenotype22,39,40. For instance, the reduced expression of
chondrocyte marker genes such as AGC or COL2, as well
as altered reactivity to IL-1b, may be related to their high
state of proliferation and continuous synthesis of proteins
associated with log-phase growth. The present study clearly
demonstrates that the presence of a-2,6-linked sialyl resi-
dues constitutes a typical feature of the differentiated phe-
notype of primary human chondrocyte cultures, whereas
the abundance of a-2,3-linked sialyl residues is associated
SA
C
B
Fig. 3. mRNA levels of N-glycan related sialyltransferases in human chondrocytes exposed to pro-inﬂammatory cytokines. PCs were treated in
duplicate with 10 ng/ml IL-1b (A) or 40 ng/ml TNF-a (B) for 24 h and SiaT expression was analyzed in duplicate using qPCR. Expression levels
were log transformed (log base of 2) and alterations with respect to the control group were displayed as log-fold changes. Mean values and SD
of six donors are presented. Asterisks indicate signiﬁcant differences with respect to untreated controls (P< 0.05). (C) Proportional distribution
of SiaT mRNA levels in untreated control cells and under exposure to IL-1b or TNF-a.
245Osteoarthritis and Cartilage Vol. 18, No. 2with the altered phenotype of chondrocytic cell lines. This
result further supports our recent observation that immortal-
ized cell lines are characterized by a reduced binding of
Sambucus nigra agglutinin (SNA)22. Importantly, differ-
ences in N-glycan sialylation among the chondrocyte cell
models were in correlation with differences in SiaT expres-
sion levels, indicating a crucial role of ST6Gal1 transcription
for the phenotype-speciﬁc sialylation of chondrocyte glyco-
proteins. Our ﬁnding on the preponderant a-2,6-sialylation
of human chondrocytes is in agreement with a previous lec-
tin histochemical study of human knee joints reporting that
chondrocytes in zones IeIV of normal hyaline cartilagewere stained to a higher degree with SNA lectin than with
Maackia amurensis agglutinin37. Interestingly, this feature
distinguishes articular chondrocytes from their progenitor
cells, the mesenchymal stem cells (MSC), which were pre-
viously shown to carry sialic acids predominantly in a-2,3-
linkage41, corresponding to the phenotype of the proliferat-
ing chondrocyte cell lines studied here.
It is tempting to speculate about the physiological rea-
sons underlying the predominant a-2,6-sialylation of chon-
drocyte glycoprotein N-glycans. Homeostasis in cartilage
tissue is maintained by chondrocyteematrix interactions
and the signals that chondrocytes receive in contact with
Fig. 4. Regulation of H5N4F1 glycan sialylation under IL-1b and
TNF-a exposure. PCs of three donors were cultured separately
for 5 days in the presence of 10 ng/ml IL-1b (grey bars) or 40 ng/
ml TNF-a (black bars). N-glycan sialylation was analyzed in tripli-
cate using LCeESI-MS. Values are meansSD relative to that
of untreated cells (grey bars) set at 1.0.
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ceptor for the glycosaminoglycan hyaluronan (HA), anchor-
ing the proteoglycan network of cartilage to the surface of
chondrocytes. Detailed studies have shown that at least
two of the ﬁve N-glycosylation sites within the HA binding
domain of CD44 can modify binding activity and that both
carry terminal a-2,3-linked sialic acids42,43. Furthermore,
modiﬁcation of CD44 glycosylation by inhibition of N-glycan
biosynthesis or enzymatic cleavage of N-glycans or termi-
nal sialic acids can trigger the activation of CD44-mediated
HA binding in various cells43e46. Therefore, the presence of
terminal a-2,3-linked sialic acid on N-glycans of the CD44
receptor inhibits the binding to HA46. Given the observation
that a-2,6-SiaTs and a-2,3-SiaTs compete for the same lim-
ited pool of N-glycan substrates47,48, it is conceivable that
the predominant expression of a-2,6-SiaTs in human chon-
drocytes facilitates the activation of CD44 receptors, which
in fact is required for a functional matrix assembly of carti-
lage. In contrast, the dominant a-2,3-sialylation of MSC41
may be a physiological requirement for migration and hom-
ing of MSC to sites of condensation and cartilage formation
in the embryo. A similar physiological mechanism has been
proposed recently for hematopoietic stem and progenitor
cells (HSPC)48. In that study, an increased relative abun-
dance of a-2,3-sialylation was found in HSPC whereas
a-2,6-sialylation was prevalent in peripheral blood-derived
CD34þ and CD34 cells. Thus, the authors suggested
that the enriched a-2,3-sialylation of HSPC might constitute
a mechanism to facilitate migration of HSPC from bone
marrow into the circulation.
In recent years, the inﬂammatory component of osteoar-
thritis has been recognized as a decisive factor for the pro-
gression of the disease. The release of cytokines such as
IL-1b or TNF-a from both the synovium and the chondro-
cytes themselves may be involved in the induction of inﬂam-
matory factors, including inducible nitric oxide synthetase,
cyclooxygenase 2, and phospholipase A249e51, as well as
proteinases that promote the destruction of cartilage matrix.
The present work shows that IL-1b and TNF-a induce alter-
ations of the differentiated chondrocyte phenotype and thatthese alterations are associated with a remarkable reorga-
nization of chondrocyte N-glycan sialylation. Strongly en-
hanced ST3Gal4 mRNA levels and the parallel drop of
ST6Gal1 expression result in reduced a-2,6- to a-2,3-sialy-
lation ratios in chondrocyte glycoprotein N-glycans. We
found that this linkage-type remodeling occurred at both
S1H5N4F1 and S2H5N4F glycans, i.e., those H5N4F struc-
tures carrying one or two sialic acid residues. Of note, this
ﬁnding is in line with recent in vivo experiments studying
N-glycans in rabbit cartilage after ligament transection20.
There, it was shown that the amount of S1(a-2,6)H5N4F1
structures signiﬁcantly decreased in cartilage tissues ex-
cised from animals with induced osteoarthritis as compared
to those of healthy animals. It appears noteworthy that the
shift towards reduced a-2,6- to a-2,3-sialylation ratios in hu-
man chondrocytes under exposure to IL-1b and TNF-a, as
observed in our study, is not a general cellular phenome-
non. As reported recently, human endothelial cells respond
to IL-1b, TNF-a, and lipopolysaccharide (LPS) with in-
creased a-2,6-SiaT mRNA levels, increased a-2,6-SiaT en-
zyme activity, and enhanced cellular binding of SNA
lectin52. In contrast, stimulation of human monocyte matura-
tion with TNF-a, IL-1b, LPS, or IFN-g leads to downregula-
tion of both ST6Gal1 and ST3Gal4 transcription19. Thus, it
can be concluded that the effect induced by pro-inﬂamma-
tory molecules on cellular sialylation is strongly dependent
on cell and tissue type. For human chondrocytes we pro-
pose a novel mechanism involving a-2,6-linked sialic acids
that represent a typical structure of the differentiated chon-
drocyte phenotype, whereas the enhanced expression of
a-2,3-linked sialic acids accompanies cellular dedifferentia-
tion induced by IL-1b and TNF-a. In light of the signiﬁcance
of sialic acids in CD44-matrix interactions, a shift towards
a-2,3-sialylation under inﬂammatory conditions may modify
the binding ability of CD44 to the HA substrate, inﬂuencing
cellular anchoring of matrix components and affecting sig-
nal transduction and gene expression53,54. Similarly to
CD44, the b1 subfamily of integrins is substrate of several
glycosyltransferases including ST6Gal155e58. Although
controversial and highly dependent on the cell type, those
studies have demonstrated the relationship between sialy-
lation of b1 integrins and adhesion to ECM components.
Since chondrocytes express a number of different integrins
including a1b1, a2b1, a3b1, a5b1, and a6b1 integrins59, the
altered N-glycan sialylation in the presence of TNF-a or
IL-1b may potentially inﬂuence the binding afﬁnity of these
receptors for their matrix substrates. This hypothesis, how-
ever, still remains to be experimentally proven.
In conclusion, the present report has revealed that the ex-
pression ratio of a-2,6- to a-2,3-linked terminal sialic acids
constitutes a signature of the differentiation status of human
chondrocytes. Whereas a-2,6-linked sialic acids are the typ-
ical structure in primary human chondrocytes, the altered
phenotype observed in chondrocytic cell lines or induced
by IL-1b and TNF-a is associated with abundant a-
2,3-linked sialic acids. This ﬁnding may shed light on the
signiﬁcance of sialylated N-glycan structures for cartilage
homeostasis and enhance our understanding of cartilage
pathophysiology. Future studies clarifying the molecular
basis, as well as the functional consequences of shifting
sialylation patterns in human chondrocyte N-glycans, are
therefore anticipated.Conﬂict of interest
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